Recent Publications
Ripretinib versus sunitinib in gastrointestinal stromal tumor....
Heinrich MC, Jones RL, George S, Gelderblom H, Schöffski P, von Mehren M, Zalcberg JR, Kang YK, Razak AA, Trent J, Attia S, Le Cesne A, Siontis BL, Goldstein D, Boye K, Sanchez C, Steeghs N, Rutkowski P, Druta M, Serrano C, Somaiah N, Chi P, Reichmann W, Sprott K, Achour H, Sherman ML, Ruiz-Soto R, Blay JY, Bauer S. Nature Medicine. 2024 Feb
KIT ATP-Binding Pocket/Activation Loop Mutations in GI Stromal Tumor....
Mühlenberg T, Falkenhorst J, Schulz T, Fletcher BS, Teuber A, Krzeciesa D, Klooster I, Lundberg M, Wilson L, Lategahn J, von Mehren M, Grunewald S, Tüns AI, Wardelmann E, Sicklick JK, Brahmi M, Serrano C, Schildhaus HU, Sievers S, Treckmann J, Heinrich MC, Raut CP, Ou WB, Marino-Enriquez A, George S, Rauh D, Fletcher JA, Bauer S. Journal of Clinical Oncology. 2024 Feb
Avapritinib treatment of aggressive systemic mastocytosis with a novel KIT exon 17 mutation
Sandow L, Town A, Heinrich MC. Leukeumia Research Reports. 2023 Dec
Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
Heinrich MC, Corless CL, Demetri GD, Blanke CD, von Mehren M, Joensuu H, McGreevey LS, Chen CJ, Van den Abbeele AD, Druker BJ, Kiese B, Eisenberg B, Roberts PJ, Singer S, Fletcher CDM, Silberman S, Dimitrijevic S, Fletcher JA. Journal of Clinical Oncology. 2023 Nov
TKI Treatment Sequencing in Advanced Gastrointestinal Stromal Tumors
Khosroyani HM, Klug LR, Heinrich MC. Drugs. 2023 Jan
Ten-Year Survivorship in Patients with Metastatic Gastrointestinal Stromal Tumors
Sutton TL, Walker BS, Billingsley KG, Corless CL, Sheppard BC, Heinrich MC, Mayo SC. Annals of Surgical Oncology. 2022 Oct